Adherence, knowledge, and perception about oral anticoagulants in patients with atrial fibrillation at high risk for thromboembolic events after radiofrequency ablation

AIMS This study aimed to: (a) determine adherence rates to oral anticoagulants in atrial fibrillation patients with a high risk for thromboembolic events postradiofrequency ablation; (b) evaluate patients' knowledge and perceptions towards oral anticoagulants; and (c) explore the impact of patients' knowledge and perceptions on treatment adherence. BACKGROUND Atrial fibrillation is a common arrhythmia associated with an increased risk of developing thromboembolic events such as stroke. Although adherence to oral anticoagulants is crucial to prevent such complications, the relationship between adherence, knowledge and patient perceptions is poorly understood in patients with atrial fibrillation at high risk for thromboembolic events after radiofrequency ablation. DESIGN A cross-sectional observational survey study was performed in a single centre. METHODS The levels of adherence, knowledge, and perception towards oral anticoagulants were assessed using the 8-item Morisky Medication Adherence Scale, Knowledge of Oral Anticoagulation Tool, Perception of Anticoagulant Treatment Questionnaire and Benefit-Risk Perception Tool, respectively. Results from these self-reported tools were analysed descriptively. A multivariable binary logistic regression model was used to identify factors associated with levels of adequate adherence. RESULTS Adequate treatment adherence was found in three-quarters of patients. The total mean knowledge score was low. Participants expressed high ease of use and low burden of treatment. Higher total knowledge and satisfaction scores were significant factors associated with higher levels of adherence. CONCLUSION There remains a huge unmet need to follow-up and educate patients with atrial fibrillation, focusing on good knowledge and correct perception of the advantages and disadvantages of oral anticoagulants. Our results suggest that increased knowledge and satisfaction rates might have a positive impact on adherence to oral anticoagulants.

[1]  P. Sanders,et al.  Ensuring adherence to therapy with anticoagulation in patients with atrial fibrillation , 2017, Heart.

[2]  P. Kirchhof,et al.  2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. , 2016, European heart journal.

[3]  Kehinde O. Obamiro,et al.  A Summary of the Literature Evaluating Adherence and Persistence with Oral Anticoagulants in Atrial Fibrillation , 2016, American Journal of Cardiovascular Drugs.

[4]  G. Caleb Alexander,et al.  Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation , 2016, Journal of the American Heart Association.

[5]  W. Petrcich,et al.  Self-reported adherence to anticoagulation and its determinants using the Morisky medication adherence scale. , 2015, Thrombosis research.

[6]  G. Lip,et al.  Optimizing stroke prevention in atrial fibrillation: better adherence and compliance from patients and physicians leads to better outcomes. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[7]  P. Whelton,et al.  Differences in cardiovascular disease risk when antihypertensive medication adherence is assessed by pharmacy fill versus self-report: the Cohort Study of Medication Adherence among Older Adults (CoSMO) , 2015, Journal of hypertension.

[8]  G. Lip,et al.  Best practice for atrial fibrillation patient education. , 2014, Current pharmaceutical design.

[9]  M. Bouvy,et al.  Beliefs about medicines in Dutch acenocoumarol and phenprocoumon users. , 2014, British journal of clinical pharmacology.

[10]  B. Martin,et al.  The Costs of Warfarin Underuse and Nonadherence in Patients with Atrial Fibrillation: A Commercial Insurer Perspective , 2013, Journal of managed care pharmacy : JMCP.

[11]  L. Friberg,et al.  [Atrial fibrillation more common than previously thought. Stroke prophylaxis needs to be improved]. , 2013, Lakartidningen.

[12]  L. Friberg,et al.  Atrial fibrillation prevalence revisited , 2013, Journal of internal medicine.

[13]  G. Hindricks,et al.  A proposal for interdisciplinary, nurse-coordinated atrial fibrillation expert programmes as a way to structure daily practice. , 2013, European heart journal.

[14]  G. Lip,et al.  Educational Intervention Improves Anticoagulation Control in Atrial Fibrillation Patients: The TREAT Randomised Trial , 2013, PloS one.

[15]  Simon Stewart,et al.  Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century. , 2013, International journal of cardiology.

[16]  Thomas Wilke,et al.  Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[17]  S. Inglis,et al.  Atrial fibrillation and thromboprophylaxis in heart failure: the need for patient-centered approaches to address adherence , 2013, Vascular health and risk management.

[18]  Danielle E. Clarkesmith,et al.  Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation. , 2013, The Cochrane database of systematic reviews.

[19]  Jeroen J. Bax,et al.  2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. , 2012, European heart journal.

[20]  M. Hori,et al.  Rivaroxaban vs. warfarin in Japanese patients with atrial fibrillation – the J-ROCKET AF study –. , 2012, Circulation journal : official journal of the Japanese Circulation Society.

[21]  M. Mordin,et al.  Development of a conceptual model of adherence to oral anticoagulants to reduce risk of stroke in patients with atrial fibrillation. , 2012, Journal of managed care pharmacy : JMCP.

[22]  M. Dimatteo,et al.  Improving the measurement of self-reported medication nonadherence: response to authors. , 2011, Journal of clinical epidemiology.

[23]  W. Budts,et al.  Patient knowledge of and adherence to oral anticoagulation therapy after mechanical heart-valve replacement for congenital or acquired valve defects. , 2011, Heart & lung : the journal of critical care.

[24]  Gregory Y H Lip,et al.  Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score. , 2011, Journal of the American College of Cardiology.

[25]  G. Lip,et al.  Identifying Patients at High Risk for Stroke Despite Anticoagulation: A Comparison of Contemporary Stroke Risk Stratification Schemes in an Anticoagulated Atrial Fibrillation Cohort , 2010, Stroke.

[26]  Gregory Y H Lip,et al.  A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. , 2010, Chest.

[27]  G. Lip.  Anticoagulation therapy and the risk of stroke in patients with atrial fibrillation at ‘moderate risk’ [CHADS2 score=1]: Simplifying stroke risk assessment and thromboprophylaxis in real-life clinical practice , 2010, Thrombosis and Haemostasis.

[28]  Gregory Y H Lip,et al.  Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. , 2010, Chest.

[29]  G. Raskob,et al.  Scoring and psychometric validation of the Perception of Anticoagulant Treatment Questionnaire (PACT-Q©) , 2009, Health and quality of life outcomes.

[30]  Marie Krousel-Wood,et al.  New medication adherence scale versus pharmacy fill rates in seniors with hypertension. , 2009, The American journal of managed care.

[31]  H. Ward,et al.  Predictive Validity of a Medication Adherence Measure in an Outpatient Setting , 2008, Journal of clinical hypertension.

[32]  G. Lip,et al.  Patient knowledge and perceptions of atrial fibrillation and anticoagulant therapy: effects of an educational intervention programme. The West Birmingham Atrial Fibrillation Project. , 2006, International journal of cardiology.

[33]  H. Billett,et al.  Impact of Adherence, Knowledge, and Quality of Life on Anticoagulation Control , 2005, The Annals of pharmacotherapy.

[34]  S. Goodacre,et al.  Atrial arrhythmias , 2002, BMJ : British Medical Journal.

[35]  Impact of Benefit Messages in Patient Package Inserts on Subjective Drug Perception , 2002 .

[36]  Martha J. Radford,et al.  Validation of Clinical Classification Schemes for Predicting Stroke: Results From the National Registry of Atrial Fibrillation , 2001 .

[37]  M. Moran,et al.  The Measurement of Efficiency in Clinical Research and Development , 1992 .

[38]  G. Backer,et al.  Impact of patient package inserts on patients' satisfaction, adverse drug reactions and risk perception: The case of nsaids for posttraumatic pain relief , 1991 .